Name: Coronavirus Australia: UQ COVID vaccine deal cancelled after HIV false positive results in participants
Brand: smh.com.au
SKU: smh-com-au-289
Availability: OnlineOnly

critic

Coronavirus Australia: UQ COVID vaccine deal cancelled after HIV false positive results in participants

preview

Australian COVID vaccine terminated due to HIV ‘false positives’We’re sorry, this feature is currently unavailable. We’re working to restore it. Please try again later.DismisscloseAdvertisementBy Log in, or to save articles for later.Normal text sizeLarger text sizeVery large text sizeAdvertisementA billion-dollar deal for the Morrison government to buy more than 50 million doses of the University of Queensland’s potential coronavirus vaccine has been abruptly terminated after several trial participants returned false positive HIV test results.UQ, working in partnership with Australian global biotech company CSL, will abandon its current clinical trials following the discovery. It informed the federal government of the initial data on Monday, which was then referred to health authorities for urgent medical advice.Sources with knowledge of the current trials said pathology tests had in the past weeks confirmed the positives were in fact false and the health of the participants has not been put at risk.Prime Minister Scott Morrison said the national security committee of cabinet agreed to terminate the purchasing agreement on Thursday, following expert health advice and fears the revelation would severely damage the Australian public’s confidence in the COVID-19 vaccination program, which is expected to begin early next year."We have prepared for this. We have planned for this. And now we're making decisions in accordance with this," he said on Friday morning.He said the government had "spread the risk" by entering into multiple agreements and had secured 20 million new doses from Oxford University-AstraZeneca and another 11 million from Novavax ."The net out-take of this is we are more likely to have the entire population vaccinated earlier rather than later by the ability to bring this manufacturing capability forward," Mr Morrison said.The UQ vaccine candidate used a protein and adjuvant platform, containing the COVID-19 spike protein and a "molecular clamp". A small component is derived from the human immunodeficiency virus, known as HIV, that is not able to infect people or replicate.AdvertisementA source with knowledge of the clinical results said although the HIV protein fragment posed "absolutely no health risk to people", they had identified that some trial participants who received the vaccine produced a partial antibody response to it.The partial antibody response had the potential to interfere with some HIV screening tests that look for the antibodies – leading to a false positive test result. It is unclear how long participants would continue to return false positive results.The source said although all participants had been told there was a remote possibility HIV markers could be found in tests during the trial, medical researchers had not expected it to occur.Health department secretary Brendan Murphy said the risk of a false-positive was seen to be "extremely low at the outset"."Everyone was very surprised at the unexpected prevalence of the false positive," Professor Murphy said.More than 200 volunteers in two groups – aged 18 to 55, and 56 and over – were involved in the phase one trial with a proportion of the participants receiving a placebo.Evidence publicly released so far from the clinical trials found the vaccine to be safe and said it produced a strong immune response able to neutralise the COVID-19 virus in laboratory based tests.A government source said the Australian government’s Science and Industry Technical Advisory Group, headed by Professor Murphy and acting Chief Medical Officer Paul Kelly, had reviewed the findings this week and recommended ending the deal.An industry source said CSL, Australia’s biggest company, will make a statement to the ASX 200 on Friday before the market opens. Both UQ and CSL will continue their research in the hope of creating a successful vaccine in coming months.Neither CSL, the University of Queensland nor the Morrison government would comment when contacted by this masthead.Vaccines typically require years of research and testing before reaching the clinic, but scientists around the world are racing to produce a safe and effective coronavirus vaccine by next year.Health Minister Greg Hunt said the decision showed the planning process was working."It's an honest explanation of some of the challenges we've had," Mr Hunt said."But, at the end of the day, 31 million new vaccines purchased for Australia, and the potential for a slightly earlier completion of the rollout with the commencement process still on track for March, subject to the approvals and the news on our vaccine candidates is strong."The University of Queensland was tasked by the Oslo-based Coalition for Epidemic Preparedness Innovations to develop a vaccine against the coronavirus in January, which was supported by an initial investment of up to US$4.5 million..Although the deal with CSL was expected to be worth up to $1 billion, the federal government was not required to pay unless the vaccine had received the green light from health authorities and large-scale production occurred. It means the funding commitment can be diverted to securing doses from other candidate vaccines.Before the UQ-CSL termination, the Morrison government had signed five agreements securing potential access to 134 million doses from different vaccines at a total cost of $3.2 billion.Researchers are testing 58 vaccines in clinical trials on humans, and at least 86 preclinical vaccines are under active investigation in animals.Log in, or to save articles for later. is Europe correspondent for The Sydney Morning Herald and The Age.Advertisement

Australian COVID vaccine terminated due to HIV ‘false positives’We’re sorry, this feature is currently unavailable. We’re working to restore it. Please try again later.DismisscloseAdvertisementBy Log in, or to save articles for later.Normal text sizeLarger text sizeVery large text sizeAdvertisementA billion-dollar deal for the Morrison government to buy more than 50 million doses of the University of Queensland’s potential coronavirus vaccine has been abruptly terminated after several trial participants returned false positive HIV test results.UQ, working in partnership with Australian...

public

Rob Harris

The Sydney Morning Herald - Australia's leading news source. Independent. Always.

Coronavirus Australia: UQ COVID vaccine deal cancelled after HIV false positive results in participants

No article scores yet.

CRITIC REVIEWS

PUBLIC REVIEWS